Solution for Endotoxin Detection in Pharmaceutical Water
Solution for Endotoxin Detection in Pharmaceutical Water
BETMATBackground and Objectives of the Solution
| Type of Pharmaceutical Water | Endotoxin Limit Requirement | Applicable Pharmacopoeial Standards (Examples) | Key Application Scenarios |
| Purified Water | No mandatory endotoxin limit (only needs to meet microbial limit requirements) | USP general chapters <1231> Water for Pharmaceutical Purposes | Preparation of oral preparations and external preparations; Production of non-sterile APIs |
| Water for Injection (WFI) | ≤0.25 EU/ml | USP general chapters <1231> Water for Pharmaceutical Purposes | Preparation of injections and eye drops; Refining of sterile APIs |
| Sterile Water for Injection | ≤0.25 EU/ml | USP general chapters <1231> Water for Pharmaceutical | Dissolution of sterile powders for injection; Dilution of injections |
| Hemodialysis Water | ≤0.25EU/ml | ISO 23500-3: 2024 Water for Hemodialysis and related therapies | Hemodialysis and hemofiltration treatments |
Selection of Detection Methods
Currently, the pharmacopoeia-recognized endotoxin detection methods are mainly divided into the "Gel-Clot Method" and "Photometric Method" (including Turbidimetric Method and Chromogenic Method). Each method has its own advantages, and the selection should be based on detection needs (such as sensitivity, degree of automation, sample characteristics, etc.):
3.1 Gel-Clot Method (Limulus Amebocyte Lysate Gel-Clot Method)
3.1.1 Principle
Based on the characteristic that Limulus Amebocyte Lysate (LAL) forms a gel after reacting with endotoxin: Endotoxin activates the serine protease catalytic pathway triggered by Factor C in LAL, converting proclotting enzyme into clotting enzyme, which in turn catalyzes the conversion of coagulogen into coagulin to form an insoluble gel. By observing whether a gel is formed after the reaction between the sample and LAL, it is determined whether the endotoxin content exceeds the limit.
3.1.2 Advantages and Applicable Scenarios
- Advantages: ① Simple operation, no need for complex instruments, and low cost.
- Applicable Scenarios: ① Routine endotoxin limit testing (e.g., compliance testing of water for injection); ② Laboratories with small sample volumes and low detection frequency.
3.1.3 Limitations
- Only qualitative or semi-quantitative (cannot provide accurate values, only determines "qualified/unqualified");
- Long detection time (usually requires incubation at 37±1°C for 60±2 minutes);
- Relies on the formation of gel to judge detection results, which is not conducive to preserving the original detection data.
3.2 Photometric Method
3.2.1 Principle
It also relies on the reaction between LAL and endotoxin, but realizes quantitative detection of endotoxin content by measuring the "turbidity change" (Turbidimetric Method) or "amount of chromogenic product generated" (Chromogenic Method) during the reaction:
- Turbidimetric Method: During the gel formation process of the reaction between endotoxin and LAL, the turbidity of the solution gradually increases. The endotoxin content is calculated by measuring the absorbance change rate or endpoint absorbance at a specific wavelength (e.g., 340 nm) and comparing it with a standard curve.
- Chromogenic Method: LAL contains a chromogenic substrate that reacts with endotoxin. After endotoxin activates coagulase, the chromogenic substrate is hydrolyzed to release a colored product. The endotoxin concentration is calculated by measuring the absorbance of the colored product (e.g., 405 nm).
3.2.2 Advantages and Applicable Scenarios
- Advantages: ① Quantitative detection is possible, facilitating trend analysis; ② High detection efficiency (can be completed in as fast as 15-30 minutes); ③ High degree of automation (enables batch detection); ④ Strong anti-interference ability.
- Applicable Scenarios: ① "Trend monitoring" of water for injection systems (e.g., continuous monitoring of changes in endotoxin content to warn of system contamination risks); ② Pharmaceutical factories with large sample volumes and high detection frequency.
3.2.3 Limitations
- High instrument cost (requires endotoxin detection equipment).
3.3 Recommendations for Method Selection
| Detection Requirement | Preferred Method | Notes |
| Pharmacopoeial compliance limit testing | Gel-Clot Method | An official method, and results can be directly used for registration and auditing |
| Quantitative analysis and trend monitoring | Photometric Method | Facilitates tracing the operational stability of the system |
| High-sensitivity endotoxin detection (e.g., hemodialysis water) | Chromogenic Method | Higher sensitivity (minimum detection limit can reach 0.001 EU/ml) |
| Batch sample detection | Photometric Method | Conducive to batch and automated detection |
features
-
4.1 Preparation Before Detection
4.1.1 Sample Collection and Processing
- Sampling Containers: Use endotoxin-free glass bottles or test tubes (subject to dry heat sterilization at ≥250°C for more than 30 minutes to remove endotoxin).
- Sampling Methods: ① Purified water/water for injection: Open the sampling valve, let water flow for 5-10 minutes (to flush the pipeline), then collect samples under aseptic conditions; ② Sampling at key points of the system: Including the outlet of the storage tank, the end of the distribution pipeline, and the front and rear of the filter, to ensure coverage of the entire water system.
- Sample Storage: Store at 4°C after collection and complete detection within 24 hours; if long-term storage is required, freeze at -20°C, but after thawing, the sample must be fully mixed to avoid uneven distribution of endotoxin.4.1.2 Reagent and Instrument Preparation
- Reagents: ① KTA Endotoxin Assay Kit (Kinetic Turbidimetric Method, 300 tests/kit), catalog number: KTA300TA.
- Instruments: 1. Kinetic Incubating Microplate Reader ELx808IUBET, catalog number: 808IUBET; 2. Endotoxin-free glass dilution tubes; 3. Pipettors with endotoxin-free tips; 4. Endotoxin-free 96-well microplates; 5. Vortex mixer; 6. Test tube rack.
- Endotoxon-Free Treatment: All utensils in contact with samples and reagents (such as test tubes, pipettes, and pipette tips) must undergo dry heat sterilization at ≥250°C for more than 30 minutes, or use disposable pyrogen-free utensils confirmed to be endotoxin-free. -
4.2 Detection Procedures
4.2.1 Preparation of Standard Curve
1. Dilute the endotoxin standard with the LAL Reagent Water provided with the kit to a series of concentrations: 10, 1, 0.1, and 0.01 EU/ml.
2. Take an endotoxin-free 96-well reaction plate, add 100 μl of the series-concentration standard to each well, and set 3 parallel wells for each concentration.
3. Add 100 μl of LAL reagent to each well, mix gently without covering the plate, and place it in the Kinetic Incubating Microplate Reader ELx808IUBET for incubation at 37°C.
4. Read the optical density (OD) at 340 nm every 30 seconds for 60 minutes.
5. Establish a standard curve using the formula: log10 Y = B(log10 X) + A (where Y = reaction time (onset time), X = endotoxin concentration). The correlation coefficient (R²) must be ≥0.98.4.2.2 Sample Detection
1. Add 100 μl of the sample to the wells of the reaction plate (set 2 parallel wells for each sample and 2 blank control wells; add 100 μl of LAL Reagent Water to each blank control well).
2. Repeat Steps 3 and 4 in the "Preparation of Standard Curve" section above to dynamically measure the absorbance of the samples.
3. Calculate the endotoxin concentration of the sample based on the standard curve.4.2.3 Interference Test (Key Verification Step)
Since pharmaceutical water may contain substances that interfere with the LAL reaction (such as residual detergents and metal ions), an interference test must be conducted for each batch of samples or after system disinfection:
1. Divide the sample into two groups: one group is spiked with a known concentration of endotoxin standard (spiked group), and the other group is not (sample group).
2. Detect the endotoxin concentration of the two groups separately, and calculate the "recovery rate" (Recovery rate = [(Concentration of spiked group - Concentration of sample group) / Spiked concentration] × 100%).
3. A recovery rate within the range of 50%-200% indicates no interference; if it exceeds this range, interference must be eliminated by diluting the sample, adjusting the pH (to 6.0-8.0), or using an interference inhibitor. -
4.3 Result Judgment and Reporting
1. Result Judgment: ① If the endotoxin concentration of the sample is ≤ the limit of the corresponding water quality (e.g., ≤0.25 EU/ml for water for injection) and the interference test is qualified, the sample is judged as "qualified"; ② If the concentration exceeds the limit or the interference test is unqualified, re-sampling and detection are required. If the result is still unqualified, a deviation investigation must be initiated.
2. Report Content: Must include sample number, sampling point, detection date, detection method, reagent batch number, standard curve parameters, sample concentration, interference test results, judgment conclusion, and the signature of the detector, to ensure the traceability of the report.
-
5.1 Daily Quality Control Measures
011. Positive Control and Negative Control: For each batch of detection, a positive control (known concentration of endotoxin standard) and a negative control (endotoxin-free water) must be set to ensure the effectiveness of reagents and no contamination during operation.
2. Consistency of Parallel Samples: The relative deviation of the detection results of parallel wells for the same sample must be ≤15%; otherwise, re-detection is required.
3. Reagent Quality Verification: For each new batch of purchased LAL reagents, standard curve validity verification must be conducted to ensure compliance with the requirements of the instruction manual.
-
5.2 Endotoxin Verification of Pharmaceutical Water Systems
021. Installation Qualification (IQ): Verify that the materials (must be 316L stainless steel or polytetrafluoroethylene) and installation of system pipelines, storage tanks, and filters (e.g., 0.22 μm sterile filter membranes, which can retain endotoxin) meet the design requirements.
2. Operational Qualification (OQ): Verify that the endotoxin content at each sampling point of the system meets the standard under normal operating parameters (such as temperature, flow rate, and pressure).
3. Performance Qualification (PQ): Continuously detect the endotoxin at each sampling point of the system for 3 batches; the system can be confirmed to be stable and reliable only if all results meet the limit requirements.
4. Re-verification: Re-verification must be conducted when the system undergoes major maintenance (such as pipeline replacement and filter replacement), process changes, or at regular intervals (usually once a year).
| Common Problem | Possible Cause | Solution |
| False negative in Gel-Clot Method (no gel formation when gel should form) | Sample pH is too high/too low (deviating from 6.0-8.0); LAL inactivation | Adjust the sample pH to neutral; replace LAL within the validity period |
| Poor linearity of the standard curve in Photometric Method | Uneven dilution of the standard; fluctuation of incubation temperature | Strictly follow gradient dilution and fully mix; ensure stable temperature of the detector |
| Unqualified sample recovery rate | Samples contain interfering substances (such as heavy metals, surfactants) | Dilute the sample (reduce the concentration of interfering substances) ; use LAL containing an interference inhibitor |
| Sudden exceedance of endotoxin in the system | Pipeline contamination (e.g., biofilm formation); filter failure | Perform CIP (Cleaning In Place) + SIP (Sterilization In Place) on the system; replace the filter |
Recommendations for Scheme Optimization
-
Expansion of Method Validation
Integrate the "Recombinant Factor C Method" (rFC Method, based on recombinant procoagulant, avoiding reliance on horseshoe crab resources and with higher specificity) as a supplement to the traditional LAL method, in line with environmental protection and sustainable development trends.
-
Personnel Training
Conduct regular training for detectors on pharmacopoeial standards, operating specifications, and instrument maintenance to ensure the standardization and accuracy of detection operations.
This solution covers the entire detection process and potential problems. Users can adjust it according to the actual scale of the pharmaceutical factory, detection needs, and existing equipment. The solution complies with pharmacopoeial standards and combines the actual application scenarios of pharmaceutical water systems. Through scientific method selection, standardized operating procedures, and strict quality control, it can effectively achieve the compliance and accuracy of endotoxin detection, providing reliable guarantee for the safety of pharmaceutical production.